Human norovirus inhibition by a human milk oligosaccharide

Virology

Volumn 508, Issue , 2017, Pages 81-89

  Koromyslova, Anna ^a   Tripathi, Shailesh ^a   Morozov, Vasily ^a,b   Schroten, Horst ^b   Hansman, Grant S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Histo blood group antigens; Human milk oligosaccharides; Norovirus

Indexed keywords

2' FUCOSYLLACTOSE; BLOOD GROUP ANTIGEN; HISTO BLOOD GROUP ANTIGEN; HUMAN MILK OLIGOSACCHARIDE; LACTOSE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; PROTEIN BINDING;

ANTIBODY COMBINING SITE; ARTICLE; BREAST MILK; CONTROLLED STUDY; DRUG STRUCTURE; GENOTYPE; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; VIRUS INHIBITION; CALICIVIRIDAE INFECTIONS; CHEMISTRY; DRUG EFFECTS; GASTROENTERITIS; HUMAN; METABOLISM; PHYSIOLOGY; VIROLOGY;

BLOOD GROUP ANTIGENS; CALICIVIRIDAE INFECTIONS; GASTROENTERITIS; HUMANS; MILK, HUMAN; NOROVIRUS; OLIGOSACCHARIDES; PROTEIN BINDING;

EID: 85019095308     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2017.04.032     Document Type: Article

References (59)

1. Atmar, R.L., Bernstein, D.I., Harro, C.D., Al-Ibrahim, M.S., Chen, W.H., Ferreira, J., Estes, M.K., Graham, D.Y., Opekun, A.R., Richardson, C., Mendelman, P.M., Norovirus vaccine against experimental human Norwalk Virus illness. N. Engl. J. Med. 365 (2011), 2178–2187.
2. Bu, W., Mamedova, A., Tan, M., Xia, M., Jiang, X., Hegde, R.S., Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 82 (2008), 5340–5347.
3. Cao, S., Lou, Z., Tan, M., Chen, Y., Liu, Y., Zhang, Z., Zhang, X.C., Jiang, X., Li, X., Rao, Z., Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81 (2007), 5949–5957.
4. Chan, M.C., Lee, N., Hung, T.N., Kwok, K., Cheung, K., Tin, E.K., Lai, R.W., Nelson, E.A., Leung, T.F., Chan, P.K., Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat. Commun., 6, 2015, 10061.
5. Chen, Z., Sosnovtsev, S.V., Bok, K., Parra, G.I., Makiya, M., Agulto, L., Green, K.Y., Purcell, R.H., Development of norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of norwalk virus gastroenteritis. J. Virol. 87 (2013), 9547–9557.
6. Choi, J.M., Hutson, A.M., Estes, M.K., Prasad, B.V., Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl. Acad. Sci. USA 105 (2008), 9175–9180.
7. Coulet, M., Phothirath, P., Allais, L., Schilter, B., Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2′-O-Fucosyllactose (2′FL). Regul. Toxicol. Pharmacol. 68 (2014), 59–69.
8. Czako, R., Atmar, R.L., Opekun, A.R., Gilger, M.A., Graham, D.Y., Estes, M.K., Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin. Vaccin Immunol. 19 (2012), 284–287.
9. Eden, J.S., Tanaka, M.M., Boni, M.F., Rawlinson, W.D., White, P.A., Recombination within the pandemic norovirus GII.4 lineage. J. Virol. 87 (2013), 6270–6282.
10. Ettayebi, K., Crawford, S.E., Murakami, K., Broughman, J.R., Karandikar, U., Tenge, V.R., Neill, F.H., Blutt, S.E., Zeng, X.L., Qu, L., Kou, B., Opekun, A.R., Burrin, D., Graham, D.Y., Ramani, S., Atmar, R.L., Estes, M.K., Replication of human noroviruses in stem cell-derived human enteroids. Science, 2016, 10.1126/science.aaf5211.
11. Etzold, S., Bode, L., Glycan-dependent viral infection in infants and the role of human milk oligosaccharides. Curr. Opin. Virol. 7 (2014), 101–107.
12. Feng, X., Jiang, X., Library screen for inhibitors targeting norovirus binding to their histo-blood group antigen receptors. Antimicrob. Agents Chemother., 2006.
13. Fu, J., Ai, J., Jin, M., Jiang, C., Zhang, J., Shi, C., Lin, Q., Yuan, Z., Qi, X., Bao, C., Tang, F., Zhu, Y., Emergence of a new GII.17 norovirus variant in patients with acute gastroenteritis in Jiangsu, China, September 2014 to March 2015. Eur. Surveill., 2015, 20.
14. Hansman, G.S., Natori, K., Oka, T., Ogawa, S., Tanaka, K., Nagata, N., Ushijima, H., Takeda, N., Katayama, K., Cross-reactivity among sapovirus recombinant capsid proteins. Arch. Virol. 150 (2005), 21–36.
15. Hansman, G.S., Natori, K., Shirato-Horikoshi, H., Ogawa, S., Oka, T., Katayama, K., Tanaka, T., Miyoshi, T., Sakae, K., Kobayashi, S., Shinohara, M., Uchida, K., Sakurai, N., Shinozaki, K., Okada, M., Seto, Y., Kamata, K., Nagata, N., Tanaka, K., Miyamura, T., Takeda, N., Genetic and antigenic diversity among noroviruses. J. General Virol. 87 (2006), 909–919.
16. Hansman, G.S., Saito, H., Shibata, C., Ishizuka, S., Oseto, M., Oka, T., Takeda, N., Outbreak of gastroenteritis due to sapovirus. J. Clin. Microbiol. 45 (2007), 1347–1349.
17. Hansman, G.S., Biertumpfel, C., Georgiev, I., McLellan, J.S., Chen, L., Zhou, T., Katayama, K., Kwong, P.D., Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J. Virol. 85 (2011), 6687–6701.
18. Hansman, G.S., Shahzad-Ul-Hussan, S., McLellan, J.S., Chuang, G.Y., Georgiev, I., Shimoike, T., Katayama, K., Bewley, C.A., Kwong, P.D., Structural basis for norovirus inhibition and fucose mimicry by citrate. J. Virol. 86 (2012), 284–292.
19. Hansman, G.S., Taylor, D.W., McLellan, J.S., Smith, T.J., Georgiev, I., Tame, J.R., Park, S.Y., Yamazaki, M., Gondaira, F., Miki, M., Katayama, K., Murata, K., Kwong, P.D., Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J. Virol. 86 (2012), 3635–3646.
20. Horm, K.M., D'Souza, D.H., Survival of human norovirus surrogates in milk, orange, and pomegranate juice, and juice blends at refrigeration (4 degrees C). Food Microbiol. 28 (2011), 1054–1061.
21. Jiang, X., Huang, P., Zhong, W., Tan, M., Farkas, T., Morrow, A.L., Newburg, D.S., Ruiz-Palacios, G.M., Pickering, L.K., Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J. Infect. Dis. 190 (2004), 1850–1859.
22. Jones, M.K., Watanabe, M., Zhu, S., Graves, C.L., Keyes, L.R., Grau, K.R., Gonzalez-Hernandez, M.B., Iovine, N.M., Wobus, C.E., Vinje, J., Tibbetts, S.A., Wallet, S.M., Karst, S.M., Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346 (2014), 755–759.
23. Kapikian, A.Z., Wyatt, R.G., Dolin, R., Thornhill, T.S., Kalica, A.R., Chanock, R.M., Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 10 (1972), 1075–1081.
24. Koromyslova, A.D., Leuthold, M.M., Bowler, M.W., Hansman, G.S., The sweet quartet: binding of fucose to the norovirus capsid. Virology 483 (2015), 203–208.
25. Koromyslova, A.D., White, P.A., Hansman, G.S., Treatment of norovirus particles with citrate. Virology 485 (2015), 199–204.
26. Kubota, T., Kumagai, A., Ito, H., Furukawa, S., Someya, Y., Takeda, N., Ishii, K., Wakita, T., Narimatsu, H., Shirato, H., Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J. Virol. 86 (2012), 11138–11150.
27. Lee, C.C., Feng, Y., Chen, S.Y., Tsai, C.N., Lai, M.W., Chiu, C.H., Emerging Norovirus GII.17 in Taiwan. Clin. Infect. Dis, 2015, 10.1093/cid/civ647.
28. Li, X., Zhou, R., Tian, X., Li, H., Zhou, Z., Characterization of a cross-reactive monoclonal antibody against Norovirus genogroups I, II, III and V. Virus Res. 151 (2010), 142–147.
29. Mallagaray, A., Lockhauserbaumer, J., Hansman, G., Uetrecht, C., Peters, T., Attachment of norovirus to histo blood group antigens: a cooperative multistep process. Angew. Chem. Int. Ed. Engl. 54 (2015), 12014–12019.
30. Mandadapu, S.R., Weerawarna, P.M., Prior, A.M., Uy, R.A., Aravapalli, S., Alliston, K.R., Lushington, G.H., Kim, Y., Hua, D.H., Chang, K.O., Groutas, W.C., Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. Bioorg. Med. Chem. Lett. 23 (2013), 3709–3712.
31. Matsushima, Y., Ishikawa, M., Shimizu, T., Komane, A., Kasuo, S., Shinohara, M., Nagasawa, K., Kimura, H., Ryo, A., Okabe, N., Haga, K., Doan, Y.H., Katayama, K., Shimizu, H., Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Eur. Surveill., 2015, 20.
32. Morrow, A.L., Ruiz-Palacios, G.M., Altaye, M., Jiang, X., Guerrero, M.L., Meinzen-Derr, J.K., Farkas, T., Chaturvedi, P., Pickering, L.K., Newburg, D.S., Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J. Pediatr. 145 (2004), 297–303.
33. Muhaxhiri, Z., Deng, L., Shanker, S., Sankaran, B., Estes, M.K., Palzkill, T., Song, Y., Prasad, B.V., Structural basis of substrate specificity and protease inhibition in Norwalk virus. J. Virol. 87 (2013), 4281–4292.
34. Parker, T.D., Kitamoto, N., Tanaka, T., Hutson, A.M., Estes, M.K., Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J. Virol. 79 (2005), 7402–7409.
35. Prasad, B.V., Hardy, M.E., Dokland, T., Bella, J., Rossmann, M.G., Estes, M.K., X-ray crystallographic structure of the Norwalk virus capsid. Science 286 (1999), 287–290.
36. Rademacher, C., Guiard, J., Kitov, P.I., Fiege, B., Dalton, K.P., Parra, F., Bundle, D.R., Peters, T., Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments. Chemistry, 2011, 10.1002/chem.201003432.
37. Rocha-Pereira, J., Jochmans, D., Dallmeier, K., Leyssen, P., Cunha, R., Costa, I., Nascimento, M.S., Neyts, J., Inhibition of norovirus replication by the nucleoside analogue 2′-C-methylcytidine. Biochem. Biophys. Res. Commun. 427 (2012), 796–800.
38. Rocha-Pereira, J., Jochmans, D., Neyts, J., Prophylactic treatment with the nucleoside analogue 2′-C-methylcytidine completely prevents transmission of norovirus. J. Antimicrob. Chemother. 70 (2015), 190–197.
39. Rockx, B.H., Vennema, H., Hoebe, C.J., Duizer, E., Koopmans, M.P., Association of histo-blood group antigens and susceptibility to norovirus infections. J. Infect. Dis. 191 (2005), 749–754.
40. Schroten, H., Hanisch, F.G., Hansman, G.S., Human norovirus interactions with histo-blood group antigens and human milk oligosaccharides. J. Virol, 2016, 10.1128/JVI.00317-16.
41. Shang, J., Piskarev, V.E., Xia, M., Huang, P., Jiang, X., Likhosherstov, L.M., Novikova, O.S., Newburg, D.S., Ratner, D.M., Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance. Glycobiology 23 (2013), 1491–1498.
42. Shanker, S., Choi, J.M., Sankaran, B., Atmar, R.L., Estes, M.K., Prasad, B.V., Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J. Virol. 85 (2011), 8635–8645.
43. Shanker, S., Czako, R., Sapparapu, G., Alvarado, G., Viskovska, M., Sankaran, B., Atmar, R.L., Crowe, J.E. Jr., Estes, M.K., Prasad, B.V., Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc. Natl. Acad. Sci. USA 113 (2016), E5830–E5837.
44. Shiota, T., Okame, M., Takanashi, S., Khamrin, P., Takagi, M., Satou, K., Masuoka, Y., Yagyu, F., Shimizu, Y., Kohno, H., Mizuguchi, M., Okitsu, S., Ushijima, H., Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J. Virol. 81 (2007), 12298–12306.
45. Singh, B.K., Leuthold, M.M., Hansman, G.S., Human noroviruses’ fondness for histo-blood group antigens. J. Virol. 89 (2015), 2024–2040.
46. Singh, B.K., Koromyslova, A., Hefele, L., Gurth, C., Hansman, G.S., Structural evolution of the emerging 2014/15 GII.17 noroviruses. J. Virol, 2015, 10.1128/JVI.03119-15.
47. Singh, B.K., Leuthold, M.M., Hansman, G.S., Structural constraints on human norovirus binding to histo-blood group antigens. mSphere 1 (2016), e00049–00016.
48. Su, X., Sangster, M.Y., D'Souza, D.H., In vitro effects of pomegranate juice and pomegranate polyphenols on foodborne viral surrogates. Foodborne Pathog. Dis, 2010, 10.1089/fpd.2010.0583.
49. Su, X., Howell, A.B., D'Souza, D.H., Antiviral effects of cranberry juice and cranberry proanthocyanidins on foodborne viral surrogates – a time dependence study in vitro. Food Microbiol. 27 (2010), 985–991.
50. Su, X., Howell, A.B., D'Souza, D.H., The effect of cranberry juice and cranberry proanthocyanidins on the infectivity of human enteric viral surrogates. Food Microbiol. 27 (2010), 535–540.
51. Tan, M., Jiang, X., Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol. 13 (2005), 285–293.
52. Tan, M., Jiang, X., Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol. 19 (2011), 382–388.
53. Tan, M., Xia, M., Cao, S., Huang, P., Farkas, T., Meller, J., Hegde, R.S., Li, X., Rao, Z., Jiang, X., Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 379 (2008), 324–334.
54. Weichert, S., Koromyslova, A., Singh, B.K., Hansman, S., Jennewein, S., Schroten, H., Hansman, G.S., Structural basis for norovirus inhibition by human milk oligosaccharides. J. Virol. 90 (2016), 4843–4848.
55. Whitehead, K., McCue, K.A., Virucidal efficacy of disinfectant actives against feline calicivirus, a surrogate for norovirus, in a short contact time. Am. J. Infect. Control 38 (2010), 26–30.
56. Yoda, T., Suzuki, Y., Terano, Y., Yamazaki, K., Sakon, N., Kuzuguchi, T., Oda, H., Tsukamoto, T., Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity. J. Clin. Microbiol. 41 (2003), 2367–2371.
57. Yu, Y., Lasanajak, Y., Song, X., Hu, L., Ramani, S., Mickum, M.L., Ashline, D.J., Prasad, B.V., Estes, M.K., Reinhold, V.N., Cummings, R.D., Smith, D.F., Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol. Cell. Proteom. 13 (2014), 2944–2960.
58. Zhang, X.F., Tan, M., Chhabra, M., Dai, Y.C., Meller, J., Jiang, X., Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections. PLoS One, 8, 2013, e69379.
59. Zhang, X.F., Huang, Q., Long, Y., Jiang, X., Zhang, T., Tan, M., Zhang, Q.L., Huang, Z.Y., Li, Y.H., Ding, Y.Q., Hu, G.F., Tang, S., Dai, Y.C., An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility. Sci. Rep., 5, 2015, 17687.